| P2093 | author name string | Lucile Ryckebüsch | |
| P2860 | cites work | Muscle diseases in the zebrafish. | Q38014653 |
| | CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish | Q38202388 |
| | The zebrafish runzel muscular dystrophy is linked to the titin gene | Q39717199 |
| | Analysing regenerative potential in zebrafish models of congenital muscular dystrophy. | Q41756663 |
| | The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy | Q41823347 |
| | Genes required for functional glycosylation of dystroglycan are conserved in zebrafish | Q46480449 |
| | Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo | Q47073103 |
| | Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology | Q47073756 |
| | Epistatic dissection of laminin-receptor interactions in dystrophic zebrafish muscle. | Q47074022 |
| | Time course of the development of motor behaviors in the zebrafish embryo | Q48325756 |
| | Out with the old, in with the new: reassessing morpholino knockdowns in light of genome editing technology. | Q50643292 |
| | Characterization of the laminin gene family and evolution in zebrafish. | Q51891008 |
| | [The revolution of the CRISPR is underway]. | Q52423327 |
| | Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. | Q52532612 |
| | Knockdown of col22a1 gene in zebrafish induces a muscular dystrophy by disruption of the myotendinous junction. | Q52644388 |
| | Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan | Q24294992 |
| | Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan | Q24316123 |
| | Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan | Q24321692 |
| | Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies | Q24647603 |
| | The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy | Q24681141 |
| | Control of muscle fibre-type diversity during embryonic development: the zebrafish paradigm | Q26823743 |
| | Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies. | Q27028125 |
| | A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish | Q27322025 |
| | Looking through zebrafish to study host-pathogen interactions | Q28086777 |
| | In vivo imaging of molecular interactions at damaged sarcolemma | Q28261975 |
| | Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality | Q28512333 |
| | Animal models of human disease: zebrafish swim into view | Q29615723 |
| | The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies | Q30499359 |
| | POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations | Q30590282 |
| | NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy | Q31105806 |
| | The dystrophin associated protein complex in zebrafish | Q31134324 |
| | Zebrafish models of collagen VI-related myopathies | Q33878282 |
| | Integrins in regulation of tissue development and function. | Q35170439 |
| | Hooked! Modeling human disease in zebrafish | Q36068284 |
| | Congenital muscular dystrophy: molecular and cellular aspects. | Q36114687 |
| | Zebrafish models flex their muscles to shed light on muscular dystrophies | Q36359190 |
| | Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome | Q36439344 |
| | Molecular mechanisms of muscular dystrophies: old and new players | Q36593241 |
| | Structure and function of skeletal muscle in zebrafish early larvae | Q36593638 |
| | Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. | Q36731388 |
| | Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy | Q37127322 |
| | Dystroglycanopathies: coming into focus | Q37852376 |
| | Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies | Q37913913 |
| P433 | issue | 10 | |
| P407 | language of work or name | French | Q150 |
| P921 | main subject | Danio rerio | Q169444 |
| P304 | page(s) | 912-919 | |
| P577 | publication date | 2015-10-19 | |
| P1433 | published in | médecine/sciences | Q3332441 |
| P1476 | title | [Potential of the zebrafish model to study congenital muscular dystrophies]. | |
| P478 | volume | 31 | |